Cardiff, United Kingdom

Gerald Curtis


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Gerald Curtis

Introduction

Gerald Curtis is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of substance testing and evaluation through his innovative patents. With a total of two patents to his name, Curtis has focused on developing methods that enhance the understanding of how substances interact with human organs and tissues.

Latest Patents

One of Gerald Curtis's latest patents involves determining the toxicity of substances by assaying their properties, fates, and effects in an ex vivo metabolically active human organ or tissue. This method utilizes normothermic perfusion with a fluid containing a test substance, providing valuable data that can be submitted to government regulatory organizations. Another patent focuses on validating substance testing using human-derived tissues and/or organs, particularly those unsuitable for transplantation. This includes assessing the suitability of the organ or tissue for testing, as well as inter-organ variability and the use of controls.

Career Highlights

Curtis is currently employed at Lifeline Scientific, Inc., where he continues to innovate in the field of biomedical research. His work has implications for regulatory submissions and the understanding of chemical disruptions in the human body.

Collaborations

Gerald Curtis has collaborated with notable colleagues, including John Brassil and David C Kravitz, to advance his research and patent developments.

Conclusion

Gerald Curtis's contributions to the field of substance testing through his innovative patents highlight his commitment to improving safety and efficacy in biomedical research. His work continues to influence regulatory practices and enhance our understanding of human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…